Resveratrol has been shown to induce autophagy and ferroptosis in lung, breast, pancreatic, ovarian cancers, as well as myeloma, leading to cell death and tumor growth inhibition [829, 830].It activates key autophagy-associated proteins, such as Beclin-1 and LC3, which promote the degradation of damaged organelles and proteins [831–833], as well as increasing the phosphorylation of AMPK and decreasing the phosphorylation of mTOR and its downstream substrates in a dose-dependent manner, leading to autophagy [832]. Here, BECN1 is linked to neoplasm.